Almanac A1C

Black Seed Oil, Simplified: Thymoquinone’s Science, Benefits, and Safer Use

Posted

by

A1C Medical Writer 2

Table of Contents
Keywords: , , , , ,

Introduction

Nigella sativa oil, commonly known as black seed oil, is natural extract obtained from the seeds of the Nigella sativa plant, native to South Asia, the Middle East, and North Africa. For centuries, it has been used in various traditional medicine systems-including Unani, Ayurveda, and Islamic Prophetic Medicine- for its broad therapeutic properties.

The oil is rich bioactive compounds such as thymoquinone, thymohydroquinone, and essential fatty acids, which contribute to its antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory effects [1-3]. Historically, black seed oil has been applied both orally and topically for a range of health concerns, including managing metabolic syndrome, supporting immune health, promoting wound healing, and alleviating conditions such as asthma, arthritis, and skin disorders like eczema and psoriasis [4,5].

Modern scientific research continues to explore and validate these traditional uses, with studies reporting promising effects in controlling blood sugar, lipid levels, inflammation, and even potential adjunct roles in managing autoimmune and neurodegenerative disorders. Notably its primary active compound, thymoquinone, is credited for most these health benefits [5].

Given its favourable safety profile and wide therapeutic potential, Nigella sativa oil is increasingly attracting interest in both medical research and clinical development for future health applications [5,6].

Phytochemical Composition and Bioactive Constituents

Comprehensive Phytochemical Profile

Nigella sativa oil (black seed oil) exhibits a rich and diverse phytochemical composition, comprising both fixed and volatile oils, as well as minor and secondary metabolites:

  • Major fatty acids: Linoleic acid (about 50-60%), oleic acid (20-24%), palmitic acid (12-13%), with smaller amounts of stearic, lauric, myristic, linolenic, and eicosadienoic acids [7-10].
  • Volatile constituents: Thymoquinone (the primary bioactive), thymohydroquinone, dithymoquinone, p-cymene, a-pinene, b-pinene, carvacrol, thymol, t-anethole and others. The content of thymoquinone, which can constitute up to 77-86% of the volatile oil fraction, varies by origin and extraction method [7,9,10].
  • Other bioactives: Saponins, alkaloids (e,g., nigellidine, nigellicine), flavonoids (quecertin, apigenin, rutin, catechin), phenolic acids (gallic, chlorogenic, vanillic, ferulic, p-coumaric acid), sterols (b-sitosterol, stigmasterol), and trace elements [7,10-13].
  • Proteins and amino acids: Seeds contain notable proteins, especially rich in essential amino acids such as arginine, glutamic acid, leucine, and lysine [9].

A GC-MS analysis confirms the presence of significant amounts of thymoquinone, b-pinene, thymol, p-cymene, palmitic, oleic, and linoleic acids [9,10].

Thymoquinone: Structure, Pharmacokinetics, and Bioavailability

  • Chemical Structure: thymoquinone is a benzoquinone derivative, specifically 2-methyl-5-isopropyl-1,4-benzoquinone, with the molecular formula C10H12O2 (molecular weight: 164.20). Its structure features a quinone ring with methyl and isopropyl substituents [14,15]. Pharmacokinetics: in animal studies (rabbits and rats), thymoquinone demonstrates rapid elimination and relatively slow absorption. After intravenous administration (5mg/kg), the clearance was 7.19ml/kg/min and the half life 63.4 min. Oral administration (20mg/kg) led to a half-life of about 275 min, with high plasma protein binding (>99%). The absolute bioavailability is about 58% following oral administration, indicating moderate absorption but significant first-pass metabolism [16-18].
  • Bioavailability: The oral bioavailability of thymoquinone is limited by poor aqueous solubility and rapid hepatic metabolism. Nano—formulations (such as thymoquinone loaded nanostructured lipid carriers) can enhance bioavailability two-to four fold compared to thymoquinone suspension, potentially improving both pharmacokinetic profile and therapeutic efficacy [18,19].
  • Formulation advances: Techniques such as encapsulation in nanoparticles or liposomes, or complexing phospholipids, also help to increase its stability and bioavailability for clinical [17-19].
Compound ClassExamplesKey Concentrations/ NotesBioactivity
Fatty AcidsLinoleic, oleic, palmitic, stearic, myristic, etc.Linoleic 50-60%, Oleic 20-24%, Palmitic 12-13%Nutritional value, anti-inflammatory
Volatile ComponentsThymoquinone, carvacrol, p-cymeneThymoquinone up to 77-86% of volatile fractionAntioxidant, anticancer, antimicrobial
AlkaloidsNigellidine, nigellicineMinorImmunomodulatory, anticancer
FlavonoidsQuecertine , apigenin, rutin, catechin,Trace-moderateAntioxidant, anti-inflammatory
Phenolic acidsGallic, chlorogenic, vanillicm ferulic, p-coumaricMinorAntioxidant
Saponins, Sterolsb-sitosterol, stigma sterolTraceCardioprotective, cholesterol-modulating
Table 1. Major Phytochemicals in Nigella sativa Oil [7-9,11,12]

This comprehensive phytochemical diversity, particularly the presence of thymoquinone, underpins the wide-ranging therapeutic activities attributed to Nigella sativa oil, making it an important subject for ongoing research in nutraceutical and pharmaceutical development.

Molecular Mechanisms of Thymoquinone

Antioxidant Mechanisms

Thymoquinone (TQ), the principal bioactive of Nigella sativa oil, exhibits potent antioxidant properties via several well-defined molecular pathways:

  • Free Radical Scavenging: Thymoquinone directly scavenges reactive oxygen species (ROS), including superoxide anions and hydroxyl radicals. It can also be reduced intracellularly to thymohydroquinone, which demonstrates even stronger radical scavenging activity, comparable to vitamin E analogs. These reduced metabolites combine non-enzymatically with antioxidants like glutathione (GSH), NADH, and NADPT, forming conjugates with high antioxidant potency [20-23].
  • Upregulation of Antioxidant Enzymes: TQ activates the Nrf signalling pathway, which subsequently increases the transcription of endogenous antioxidant proteins such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and glutathione-S-transferase [20,22]. This result in reduced lipid peroxidation, DNA damage, and overall oxidative stress in various tissues.
  • Redox Cycling: Thymoquinone can undergo both enzymatic and non-enzymatic redox cycling, producing either its antioxidant form (thymohydroquinone) or a pro-oxidant semiquinone intermediate, depending on the cellular environment. Although this allows for both antioxidant and, at times, pro-oxidant actions, the balance typically favours cytoprotection under physiological conditions [20,22,24].
  • Lipid Peroxidation Inhibition: Thymoquinone has been shown to reduce markers of lipid peroxidation (e.g., malondialdehyde), aiding membrane stabilization and cellular protection against oxidative injury [20,22].

Anti-inflammatory Mechanisms

Thymoquinone’s anti-inflammatory action is multifaceted, involving the modulation of several signalling pathways and inflammatory mediators:

  • Inhibition of NF-kB and AP-1 Pathways: TQ suppresses the activation and nuclear translocation of NF-kB, a major transcription factor that regulates the expression of many pro-inflammatory cytokines and enzymes (such as TNF-a, IL-1b, IL-16, and COX-2). Similarly, TQ inhibits the AP-1 pathway, limiting the production of inflammatory mediators [25-29].
  • Suppression of Pro-inflammatory Cytokines: It downregulates major pro-inflammatory cytokines including TNF-a, IL-1b, IL-6, IFN-g, reducing the amplification of inflammatory cascades in acute and chronic disease models [25-28].
  • COX-2 Inhibition: TQ has been specifically shown to inhibit cyclooxygenase-2( COX-2) and downstream prostaglandin E2 (PGE2) production, contributing to reduced inflammation and pain perception, as well as decreased tumor promotion [26,28,30].
  • Activation of PPAR-g: TQ upregulates peroxisome proliferator-activated receptor gamma (PPAR-g), which exerts anti-inflammatory and anti-apoptotic effects and further modulates lipid metabolism and immune response [30]
  • MAPK Pathway and PI3K/Akt Modulation: TQ negatively regulates MAPK and PI3K/Akt signalling, which are critical for the expression of inflammatory genes and cellular stress responses [26-28]. This also leads to reduced phosphorylation and nuclear activity of STAT3, limiting cell proliferation and enhancing anti-inflammatory responses
  • Nrf2-ARE Activation: This pathway not only boost antioxidant defenses but also inhibits inflammation by downregulating expression of pro-inflammatory genes [22,28].
MechanismMolecular TargetEffectReference
AntioxidantFree radicals (ROS, RNS)Direct scavenging, prevention of oxidative damage[20-22]
Nrf2 pathwayUpregulates SOD, catalase, GPx, GST[20,22]
Anti-inflammatoryNF-kB, AP-1Inhibits translocation, reduces cytokine production[25-29]
COX-2, PGE2Suppresses enzyme & mediator, reduces inflammation[27,29,30]
Cytokines (TNF-a, IL-1b, IL-6, IFN-g)Downregulates pro-inflammatory cytokines[26-28]
PPAR-gUpregulates anti-inflammatory transcription factor[30]
Anti-inflammatory/AntioxidantMAPK, PI3K/Akt, STAT3Inhibits pathway, reduces inflammation and proliferation[26-28]
Table 2. Key Molecular Targets of Thymoquinone

Thymoquinone acts through a combination of direct ROS scavenging, upregulation of antioxidant defenses, and suppression of multiple major inflammatory pathways-especially NF-kB, COX-2, cytokines, and related signalling. Its diverse molecular actions contribute to broad-spectrum antioxidant and anti-inflammatory effects, underlying its therapeutic value in various diseases [20,22,27-29].

The Omega-6 Paradox: Reconciling Pro-inflammatory Content with Anti-inflammatory Effects

Omega-6 Content and Conventional Understanding

Black seed oil (Nigella sativa oil) is notably rich in linoleic acid, an omega-6 polyunsaturated fatty acid (PUFA), with concentrations typically ranging from 47% to 62% depending on origin and extraction method [31]. It also contains minor omega-6 fractions such as eicosadienoic acid (about 2%) [31]. Traditionally, higher dietary intake of omega-6 fatty acids, especially linoleic acid and its derivative arachidonic acid, is believed to contribute to a pro-inflammatory milieu. This is because arachidonic acid is a precursor to a variety of potent pro-inflammatory eicosanoids, including prostaglandins and leukotrienes, through cyclooxygenase (COX) and lipoxygenase (LOX) pathways [32,33].

Epidemiological and mechanistic studies have linked excessive intake and high omega-6/omega-3 ratios with the promotion of inflammation, atherosclerosis, and an increased risk of chronic diseases-hence the “omega-6-paradox” when considering black seed oil’s broad anti-inflammatory efficacy [32-34].

Mechanistic Resolution of the Paradox

Despite its high omega-6 content, black seed oil exhibits strong anti-inflammatory and antioxidant effects. This apparent contradiction is explained by several key factors:

  • Unique Phytochemical Matrix: Black seed oil contains a complex mixture of bioactive compounds, most notably thymoquinone- a potent antioxidant and anti-inflammatory agent- as well as other phytochemicals such as thymoquinone, thymohydroquinone, and alkaloids. Thymoquinone, even in small concentrations (<1%), can upregulate antioxidant enzymes, scavenge free radicals, and act on multiple inflammatory pathways, including NF-kB and COX-2 inhibition. These actions can override or balance the expected pro-inflammatory influences of omega-6 PUFAs within the same oil [35].
  • Fatty Acid Profile Matters: Linoleic acid (the principal omega-6 in black seed oil) is not inherently pro-inflammatory; its conversion to arachidonic acid and subsequent metabolism into eicosanoids is context-dependent. The presence of omega-9 oleic acid (20-25%) and minor omega-3s in the oil may modulate this effect by competing for incorporation into cell membranes and metabolic pathways, thus influencing eicosanoid profiles and inflammatory responses [37]
  • Synergy Overcomes Paradox: The matrix of black seed oil means thymoquinone, omega-6, and other antioxidants act synergistically. Thymoquinone reduces the production of pro-inflammatory cytokines (e.g., IL-6, TNF-a) upregulates endogenous antioxidant defenses, counteracting the theoretical pro-inflammatory signalling from omega-6 metabolites. Moreover, black seed oil may favor the formation of anti-inflammatory lipid mediators or directly inhibit enzymes essential for the production of pro-inflammatory eicosanoids [32,35].
  • Clinical Evidence: Studies show that supplementation with black seed oil leads to reduced markers of inflammation and oxidative stress despite its high omega-6 content. This has been attributed not only to the fatty acid composition but also the “protective” impact of thymoquinone and related bioactives [35,37]

While black seed oil is rich in omega-6 PUFAs traditionally associated with pro-inflammatory outcomes, its prominent content of thymoquinone and other bioactives provides potent antioxidant and anti-inflammatory activities. These unique constituents modulate the inflammatory response and effectively override the expected effects of omega-6, illustrating the importance of the entire phytochemical context- not just one nutrient- in determining biological outcomes [31-33,36].

Clinical Applications and Evidence-Based Dosage Recommendations

Respiratory Disorders

  • Clinical Applications:
    • Black seed oil (Nigella sativa) is used as an adjunct therapy for asthma, chronic obstructive pulmonary disease (COPD), and allergic airway inflammation.
    • Clinical trials show improvements in lung function (FEV1, FVC, PEF), bronchodilation, and reduced asthma attack frequency, as well as decreased inflammatory markers (IL-6, TNF-a) and oxidative stress in COPD patients [38,39,40,41].anti-inflammatory and bronchodilatory effects are key mechanism.
  • Dosage Recommendations:
    • Oral: Studies commonly use 1-2g/day of oil or extract, or about 2.5 mL twice daily for 8-12 weeks. Doses of up to 5 mL/day have also been reported as safe and effective in combination therapies [5,38]
    • Nebulized extract: has been studied in asthma, but oral supplementation is more common.

Dermatological Conditions

  • Clinical Applications
    • Effective for eczema, acne, psoriasis, and wound healing due to its anti-inflammatory, antioxidant, and antimicrobial actions.
    • Topical application reduces severity scores in eczema and acne and supports scar and wound healing [42,43].
  • Dosage Recommendations
    • Topical: 5-10% black seed oil diluted in carrier oils, applied once or twice daily. For acne, direct application twice daily for up to 60days showed significant benefit.
    • Patch testing is strongly recommended before initial use to prevent allergic reactions.

Metabolic Disorders

  • Clinical Applications
    • Used for adjunct management of diabetes, metabolic syndrome, obesity, and dyslipidaemia.
    • Clinical evidence demonstrates reduced fasting glucose, HbA1C, LDL, triglycerides and improved insulin resistance and lipid profiles [5,44,45].
  • Dosage Recommendations
    • Oral: 1-3g/day for seed powder or about 2.5-5mL/day for oil.
    • For type 2 diabetes, 2g/day is identified as an optimal dose in some trials, with 3g/day associated with additional lipid-lowering benefits [5].

Neurological and Psychiatric Conditions

  • Clinical Applications
    • Studied as adjunct therapy for epilepsy, depression, cognitive impairment, mood and opioid withdrawal.
    • Research shows improvements in seizure frequency (not consistently across studies), memory, cognition, attention, and anxiety scores; some mood-enhancing and neuroprotective effects in depression and antipsychotic-induced toxicity [5,46-48].
  • Dosage Recommendations
    • Oral: 500mg twice daily or up to 40-80 mg/kg/day for oil. For cognition, 500mg capsules once or twice daily for 4-9 weeks showed positive results.
    • For depression, 500 mg daily capsules of seed extract for 10 weeks have been beneficial [48].

Immunomodulatory Applications

  • Clinical Applications
    • Black seed oil exhibits immunomodulatory effects- improving immune balance, reducing autoimmune inflammation, and potentially suppressing allergic responses.
    • Clinical and preclinical evidence supports its use in asthma, rheumatoid arthritis, and other immune-mediated diseases through modulation of cytokines, lymphocyte proliferation, and regulation of Treg/Th17 balance [5,49,50].
  • Dosage Recommendations
    • Oral: 1-3g/day of seed or 0.3-3mL/day of oil are commonly used in studies.
    • The therapeutic window varies with the condition and immune status, and combination with standard therapy is typical for chronic conditions [49,50].

Safety and General Guidance

  • Black seed oil is generally safe when used short term ( up to 3 months) and within standard dosages (1-5mL/day)
  • Side effects are rare and mild but can include gastrointestinal upset and dermatitis with topical use.
  • Special caution healthcare consultation are advised for individuals with chronic illness, those using multiple medications, or those who are pregnant.

In summary, black seed oil demonstrates evidence-based efficacy in respiratory dermatological, metabolic, neurological, psychiatric, and immunomodulatory conditions at a standard doses of 1-3g/day (seed/powder) or 1-5 mL/day (oil) orally and 5-10% concentration topically. Clinical applications are best supported when black seed oil is used as adjunct therapy, not as a standalone treatment for severe disease [5,38,42,49,50].

Figure 1. Nigella Sativa Clinical Applications

Comparative Analysis of Supplementation Forms

Liquid Oil Formulations

  1. Cold-Pressed Oil
    • Extraction: Mechanically extracted without chemical solvents or high heat, preserving the full spectrum of lipophilic bioactives, especially thymoquinone, essential fatty acids (omega-6/linoleic, omega-9/oleic), and volatile compounds [51,52].
    • Bioactive Content: Generally high in thymoquinone and polyunsaturated fatty acids, but actual thymoquinone levels vary with seed origin and method [51,53].
    • Bioavailability & Stability: Susceptible to oxidation from heat, light, and air. Requires protection (dark bottles, refrigeration) for maximum efficacy and shelf-life. Direct ingestion (liquid) offers immediate absorption but variable systemic distribution and taste aversion for some users [51,53].
    • Clinical Use: Most clinical studies use dosages of 2.5-5mL/day for up to 8-12 weeks, with documented safety and efficacy for cardiovascular and metabolic applications [53].
  2. Supercritical Fluid Extractions (SFE)
    • Extraction: Uses CO2 at high pressure and controlled temperatures. Yields higher concentrations of oil with potentially enhanced purity and selectivity for volatile constituents (e.g., thymoquinone, phenolics) [54,55].
    • Bioactive Content: Some studies suggest SFE yields oil with higher thymoquinone and total phenolic compounds compared to cold-pressed oil, through exact content depends on process conditions [52,54].
    • Bioavailability & Stability: Improved oxidative stability, often superior to conventional cold-pressed oil [52]. Liquid form still shares limitations regarding taste and dosing accuracy.

Solid Oral Formulations

  1. Soft Gel Capsules
    • Formulation: Soft gelatin or vegetable capsules filled with either cold-pressed or CO2 extracted oil, sometimes combined with co-extracts (e.g., rose oil, milk thistle).
    • Bioavailability & Dosing: Capsules offer more precise dosing, better taste masking and improved compliance. Capsule shells protect oil from oxidation and mask taste without impairing absorption [53].
    • Clinical Use: Dosages typically equivalent to 1-2 mL oil per day, with 500 mg per capsule being standard. Capsules may improve the delivery of bioactives to the intestine, supporting stable systemic absorption.
    • Safety: Comparable to oil in safety/tolerance over short periods; preferred for individuals who dislike the strong taste of oil [53].
  2. Standardized Extracts
    • Formulations: Solid extracts or encapsulated beadlets /microcapsules, standardized to known thymoquinone (TQ) content, sometimes combined with matrix carriers for taste-masking and enhanced stability [53,56].
    • Bioactivity & Efficacy: Guarantee of consistent TQ dosing; enhanced protection from oxidation and environmental degradation [56].
    • Bioavailability: Microcapsulation and nano-formulation advances (such as self-emulsifying systems or liposomes) increase thymoquinone stability, improve intestinal absorption, permit controlled release, and may enhance therapeutic response [56,57,58].
    • Clinical Use: Studies use 500mg/day to 1.5g/day in chronic applications, e.g., ThymoQuin® capsules delivering 15 mg TQ daily [53,59].
AttributeLiquid Oil (Cold-Pressed/SFE)Soft Gel Capsules/Standardized Extract
Bioactive ConsistencyVariable by batch and extractionHigh-standardized TQ content [51,53]
Stability/OxidationSensitive (needs protection)Encapsulation improves stability [54,57]
Taste/ComplianceStrong, may be unpalatableTasteless, mask odor-better compliance [54]
Dosing AccuracyVolume measures, lower precisionFixed doses, high precision [53,59]
Gastrointestinal ToleranceSome report GI irritationGenerally better tolerated
BioavailabilityImmediate but variableEnhanced with some encapsulated forms [54,57,58]
CostUsually lower (bulk oils)Higher due to formulation, but less waste
Table 3. Key Comparative Points

In summary, liquid black seed oil (cold-pressed or SFE) provides a broad phytochemical profile, but faces issues of oxidative instability, batch-to-batch variation, and taste aversion. While solid formulations (capsules and standardized extracts) deliver more consistent and stable doses of active ingredients like thymoquinone, enhance patient acceptability, and benefit from advances in nano- and microencapsulation for higher bioavailability and efficacy [53,54,57]. For chronic supplementation, solid oral forms with standardized thymoquinone content are generally preferred for safety, convenience, and precision, while liquid oils may be advantageous for rapid onset or topical use [51,53,54,57].

Novel Delivery System

Nano emulsions

Description & Technology:

  • Nanoemulsions are oil-in-water or water-in-oil systems with droplet sizes typically between 100-2000nm, stabilized by surfactants [60,61].
  • High-energy methods (ultrasonication, high-pressure homogenization) and low energy methods (phase inversion, spontaneous emulsification) are employed to achieve small, stable droplets for black seed oil delivery [61,62].

Advantages:

  • Enhanced Bioavailability: Nano-sized droplets dramatically improve the solubility and gastrointestinal absorption of lipophilic actives, such as thymoquinone and other phytochemicals in black seed oil [60,63].
  • Improved Stability: Nanoemulsions protect oil constituents from oxidation and degradation, maintaining therapeutic efficacy during storage [60,.
  • Faster and More Efficient Penetration: Due to their size and high surface area, nanoemulsions facilitate faster drug absorption, greater tissue penetration, and, for topical application, improved dermal delivery [60,61,62].
  • Clinical and Functional Outcomes: Black seed oil nanoemulsions show superior antimicrobial, anti-inflammatory, and antioxidant effects, partly because of improved delivery to target tissues [60,63,64].

Examples:

  • Studies formulated stable black seed oil nanoemulsions using Tween 80 and sorbitol, achieving optimal droplet sizes (~21.5nm), zeta potential (~31.5mV), and excellent stability in artificial gastric and intestinal fluids [61].
  • Alginate nanoemulsions of black seed oil prepared via ultrasonication reached particle sizes as small as ~346nm, with droplet and polydispersity index influenced by energy input and flow rate [62].

Nanoparticles

Description & Technology:

  • Encapsulation of black seed oil actives within polymeric nanoparticles (e.g., alginate, chitosan), lipid-based nanoparticles, or even metallic nanoparticles (e.g., silver, iron oxide) have been explored for sustained delivery and tissue targeting [65,68].

Advantages:

  • Controlled Release: Nanoparticles provide sustained and targeted release of active constituents, allowing prolonged biological activity and lower dosing frequency [64,68].
  • Enhanced Tissue Targeting: They enable easier crossing of biological barriers (e.g., blood-brain, gastrointestinal), enhancing bioefficacy in neurological and systemic applications [64,68].
  • Synergistic Effects: Co-formulation with other nanoparticles (e.g., silver, iron oxide) can potentiate both antimicrobial and anticancer activities [65,68].
  • Functional Studies: Black seed oil nanoparticles have demonstrated potent antibacterial, antifungal, antioxidant, and anti-inflammatory effects, with notable improvement over conventional oil in preclinical models [65,68].

Examples:

  • Silver or iron oxide nanoparticles synthesized using black seed oil as a reducing an capping agent exhibit significant antibacterial activity and radical scavenging capacity [65,68].
  • Polymeric and lipid-based nanoparticles carrying black seed oil have shown improved biological effectiveness in models of infection, inflammation, and cancer [64,68].

Phytosomal Formulations

Description & Technology:

  • Phytosomes are complexes formed between phospholipids and plant actives (e.g., thymoquinone), improving solubility, stability, and cell membrane permeability [57].
  • Formulation typically involves the creation of a molecular complex between black seed oil constituents and phospholipids (e.g., phosphatidylcholine)

Advantages:

  • Superior Absorption: Phytosomal black seed oil preparations display higher oral bioavailability, as phospholipids aid the transport of actives across intestinal barriers [57].
  • Membrane Integration: improved capability to merge with biological membranes enhances tissue distribution and may potentiate topical or systemic effects [57].
  • Stability: Phytosomal complexes provide additional protection for sensitive actives against enzymatic and oxidative degradation [57]

Examples:

  • Thymoquinone phytosomal gels have demonstrated enhanced permeation and effectiveness in topical applications, as well as superior pharmacokinetics profiles in animal studies.
Delivery SystemKey FeaturesBioavailabilityStabilityApplicationsReferences
NanoemulsionsTiny droplets, surfactant-stabilizedHighImprovedOral, topical, antimicrobial[60,61,62,63]
NanoparticlesEntrapped in polymers/lipids/metaloxide; targetedHighSuperiorOral, IV, targeted therapy[64,65,68]
PhytosomalPhospholipid complex, mimic cell membranesVery HighStrongOral, topical[57]
Table 4. Comparative Attributes

So in conclusion, novel drug delivery systems-nanoemulsions, nanoparticles, and phytosomal complexes-markedly improve the stability, absorption, and targeted effectiveness of black seed oil and its actives. These advances address traditional formulation and bioavailability challenges, heralding more effective clinical applications in both oral and topical therapies [57,60-65,68].

Comparative Clinical Efficacy

Metabolic and Cardiometabolic Disorders

  • Glycaemic and Lipid Control: Multiple randomized controlled trials (RCTs) support the adjunctive use of black seed oil in improving fasting blood glucose, HbA1C, LDL-cholesterol, triglycerides, and total cholesterol in patients with type 2 diabetes and metabolic syndrome. Combination with statins enhances lipid lowering and reductions are generally more significant with oil than with seed powder [5] . Some studies also report positive effects on body weight and waist circumference but findings are mixed, and not all studies show consistent effects [5].
  • Comparative Findings: Black seed oil, especially at 2-5mL/day dosages, often outperforms placebo and sometimes standard treatments in improving lipid and glycaemic profiles, though it is best used as adjunct therapy rather than a stand alone intervention [5,44,67].

Respiratory Disorders

  • Asthma and COPD: Clinical trials in asthma patients show that black seed oil supplementation improves lung function indices (FEV1, FVC, PEF), reduces asthma attack frequency, and lowers inflammatory markers [5,41,67]. For COPD, adjunctive therapy with black seed oil significantly improves pulmonary function, reduces pro-inflammatory cytokines (IL-6, TNF-a), lowers oxidative stress markers, and enhances antioxidant enzyme activities compared to standard therapy alone [41].
  • Prophylactic Benefits: Some studies have reported significant symptom improvement in allergic rhinitis and in the prevention of upper and lower respiratory tract illnesses when compared with routine therapies [5].

Dermatological Conditions

  • Wound and Soft Tissue Healing: Black seed oil is as effective or more effective than conventional wound dressings (such as Alvogyl) for managing dry sockets and reducing inflammation in oral surgery, as well as for healing skin wounds. Studies in acne and psoriasis also indicate superior or comparable effects to conventional treatments, due to its anti-inflammatory and antimicrobial properties [68,69].
  • Pain Relief: Topical black seed oil shows better pain relief than some standard topical anti-inflammatories, such as diclofenac gel, in pain models [7-] .

Infectious and Digestive Disorders

  • Antimicrobial Activity: Black seed oil and its active component thymoquinone demonstrate significant clinical and in vitro activity against gram-positive bacteria (like Staphylococcus aureus), Helicobacter pylori, and certain multidrug-resistant pathogens [35]. In digestive tract, black seed oil at optimal dosages can match the efficacy of triple therapy for eradicating H.pylori [5].
  • Fungal and Parasitic Infections: It is effective as an adjunct to standard therapies for vaginal candidiasis and has antiparasitic effects against cestode infections [5.]

Neurological and Psychiatric Conditions

  • Seizure and Cognition: Adjunctive use of black seed oil in epilepsy, especially in pediatric populations, reduces seizure frequency. Some human and animal studies suggest improvements in cognition and reduction in depression or social behaviour deficits, possibly due to its antioxidant and anti-inflammatory actions [5,71].

Immunomodulatory and Anti-inflammatory Actions

  • Black seed oil reduces systemic markers of inflammation, including CRP, IL-6, and TNF-a, in diverse inflammatory and autoimmune states [5,72,73]. In rheumatoid arthritis and other autoimmune diseases, adjunct use leads to reduced joint pain and inflammation, though larger studies are needed.

Tolerability and Safety

  • Adverse effects are rare and generally mild, including minor gastrointestinal complaints or allergic reactions with topical use [5,. Black seed oil is regarded as safe in most clinical contexts when dosed at standard levels (1-5mL/day)
Condition/ UseClinical Evidence vs.Standard/ PlaceboNotes
Diabetes/ MetabolicImproved lipids, glucose vs placebo; oil better than powder [5]Adjunct to statins/ metformin optimizes effects
COPD/ AsthmaAdded lung function, reduces inflammations vs control [5,67]Best as add-on therapy
Skin/ WoundAs or more effective than conventional dressings[68,69,70]Accelerates healing, reduces pain
H,pylori/ gastrointestinalComparable to triple therapy for H.pyloriEffective at optimal (2g/day) dose
Inflammation/ ImmunityReduces CRP, IL-6, TNF-a, better symptom scores [5,72,73]Adjunct value, especially in chronic disease
Table 5. Key Comparative Efficacy Findings

In summary, black seed oil shows broad comparative clinical efficacy-especially as an adjunct therapy-in metabolic, inflammatory, respiratory, dermatological, infectious, and some neurological conditions. While result are generally favourable and suggest merit above placebo and/ or standard care in multiple indications, variation remains based on formulation, dosage, and study population. Its tolerability and safety profile are well-supported in clinical studies [5,44,67-70,72,73].

Safety profile and Adverse Effects

General Safety Profile

  • Low Toxicity in Animal and Human Studies: Extensive research, including acute, subacute, and chronic toxicity studies in animals and clinical trials in humans, generally finds black seed oil (Nigella sativa oil) to be safe when used in typical supplemental doses (generally 1-5mL/day or up to 3g/day of seeds for periods up to three months) [74,75].
  • Lethal Dose (LD50): Oral LD values to Nigella sativa oil in mice are high (ranging from 3,000mg/kg to nearly 29mL/kg depending on extract type), indicating low acute toxicity [74,75].
  • Key Organ Functions: No significant alterations in hepatic, renal , or hematological parameters have been reported in clinical studies of healthy volunteers or in most patients taking oral doses in common therapeutic ranges [74,76].

Common and Mild Adverse Effects

  • Gastrointestinal: The most frequently reported side effects are mild gastrointestinal disturbances, such as bloating nausea, upset stomach constipation, vomiting, or a burning sensation. These are generally transient and resolve with continued use or dose reduction [77].
  • Skin Reactions: Topical use may cause allergic contact dermatitis, eczema, and rarely, severe skin reactions like erythema multiforme in sensitive individuals [74,77,78].
  • Other Reactions: Rare cases hypoglycaemia have been observed in susceptible populations, and contact with essential oil preparations may increase the risk for irritation or allergic response [74,77].

Rare or Severe Adverse Events

  • Hepatotoxicity and Nephrotoxicity: Case reports have documented acute liver failure, rhabdomyolysis, and acute kidney injury in individuals with underlying diseases, particularly when used at high doses or in conjunction with other medications or renal failure. Such events are extremely rare but highlight the importance of caution in vulnerable populations [79,80].
  • Other Organ Toxicity: Animal studies indicate that very high doses may rarely cause respiratory distress, coagulation problems, or other organ toxicity, but these effects are not seen with standard, clinically recommended doses [74,81].
  • Cytochrome P450 Interaction: High intake may inhibit certain liver enzymes (CYP2D6 and CYP3A4), affecting drug metabolism and potentially exacerbating drug interactions [74].
  • Blood Thinning: Black seed oil may have mild antiplatelet effects and theoretically increase the risk of bleeding, particularly in those with bleeding disorders or taking anticoagulant/ antiplatelet medications [82].

Safety in Special Populations

  • Pregnancy and Lactation: Black seed oil should be avoided in pregnancy (especially in high or supplemental doses) due to possible uterine effects. Safety in lactation and for young children is not established; use is not recommended without physician guidance [76,82].
  • Chronic Illness: Caution is also warranted in individuals with liver, kidney, or bleeding disorders, and those on multiple medication- especially anticoagulants, antihypertensives, antihyperglycemics, and immunosuppressants- due to possible interactions or additive effects [76].

In summary, black seed oil in generally safe with a wide margin of safety at recommended doses and for short-term use. Most adverse effects are minor and self-limiting. But do void excessive, chronic, in unsupervised use especially vulnerable populations such as patients with comorbidities or pregnancy which should be avoided except under medical supervision [74,79].

Limitations of Current Research and Future Directions

Methodological Limitations

  1. Low Methodological Quality and Reporting Standards Reviews of meta-analyses and systematic reviews have highlighted that most existing studies on black seed oil (Nigella sativa) are of low or critically low methodological quality, with only a few reaching moderate quality. Common issues include inadequate randomization, unclear allocation concealment, poor blinding, incomplete reporting, and lack of pre-registered protocols [83].
  2. Small Sample Sizes and Short Duration Many clinical trials feature small numbers of participants (often <100 per group) and short intervention periods (typically 4-12weeks), limiting statistical power and the assessment of long-term efficacy and safety [83]. Large-scale, long duration studies are scarce.
  3. High Heterogeneity There is considerable inconsistency in results, reflecting high heterogeneity in trial populations, intervention forms (seed, oil, extract, capsule), doses (0.5-6g or 2.5-5mL per day), and treatment durations. This limits the comparability and generalizability of findings [83].
  4. Inconsistent Characterization and Standardization Many studies do not clearly define or standardize the type of black seed oil, extraction method, or thymoquinone content, making it difficult to compare results or replicate studies [83,84].
  5. Insufficient Safety and Adverse Event Reporting Adverse effects and long-term safety are often underreported. Many meta analyses and clinical trials lack systematic monitoring and reporting of side effects, making safety assessment challenging [83].
  6. Publication and Funding Bias Several studies receive industry support, and there is a risk of publication bias, with positive results more likely to be published. This may inflate perceived efficacy and minimize recognition of adverse outcomes or null results [84].

Future Research Priorities

  1. High-Quality, Well-Powered Randomized Controlled Trials (RCTs) There is a strong need for rigorously designed, multicentre RCTs with larger sample sizes (minimum several hundred per group), longer follow-up periods, and robust blinding and allocation methods to genuinely assess efficacy and safety across various conditions [5,83,84].
  2. Standardization of Intervention and Reporting Future studies should use well-characterized, standardized extracts or oils with transparent reporting of thymoquinone content, extraction method, formulation, dose, duration, and adherence [83,84]. Clear documentation of protocol registration and adherence to reporting guidelines (e.g., CONSORT, PRISMA) is crucial.
  3. Long-Term Safety Studies Given the potential for chronic or high-dose use in some populations, systematic, long-term safety monitoring and reporting in human studies are required to accurately define the risk profile and contraindications [74,83].
  4. Mechanistic and Translational Research Further preclinical and translational studies are required to elucidate the mechanisms of action, interactions with drugs and other phytochemicals, bioavailability differences between novel formulations, and to optimize delivery system (e.g., nanoformulations, phytosomes) [54,84].
  5. Comparative Effectiveness and Population -Specific Studies Studies directly comparing black seed oil to current standard therapies and placebo are limited [85]. Trials should also explore population-specific responses, including paediatric, pregnant, and elderly groups, and investigate pharmacogenomic factors that might influence efficacy or safety [86].
  6. Optimal Dose, Duration, and Combination Therapies The optimal therapeutic dose and duration for different indications have not been well established. Research should also assess the safety and efficacy of black seed oil in combination with conventional drugs and across different disease states [84,85]. In summary, while black seed oil shows promise for a range of health conditions, current evidence is limited by low methodological quality, small sample sizes, inconsistent formulations, and underreporting of adverse events. High-quality, standardized, and transparent clinical research focusing on efficacy, safety, mechanisms, dosing, and comparative effectiveness is essential to better define its role in modern therapy [5,74,83,84,85,86].

Conclusion

Nigella sativa oil (black seed oil) is a time-honoured remedy with a wide array of traditional and modern therapeutic applications. Its rich phytochemical profile dominated by thymoquinone and supported by a variety of volatile oils, fatty acids, alkaloids, and flavonoids-underscores its multifaceted antioxidant, anti-inflammatory, antimicrobial, immunomodulatory effects. Contemporary clinical evidence supports its use-primarily as adjunct therapy-in metabolic, respiratory, dermatological, and immune-related disorders. Black seed oil is generally well-tolerated, with rare and usually mild adverse effects reported when used within standard dosages. Advances in delivery systems, such as nano-formulations and phytosomal complexes, are enhancing bioavailability and therapeutic outcomes. While promising, further high-quality standardized research is necessary to optimize dosing, formulations, and confirm long-term safety and efficacy for wider clinical application.

References

  1. Islam, Rahman S.M. Ashrafur, Ahmed A. Black cumin (Nigella sativa L.) essential oil and aroma quality. Elsevier eBooks [Internet]. 2022 Nov 11;71–87. Available from: https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/nigella-sativa
  2. Fatemeh Forouzanfar, Sedigheh B, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iranian Journal of Basic Medical Sciences [Internet]. 2014 Dec;17(12):929. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4387228/
  3. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal of Tropical Biomedicine [Internet]. 2013 May;3(5):337–52. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642442/
  4. Contributors WE. Black Seed: Are There Health Benefits? [Internet]. WebMD. 2024. Available from: https://www.webmd.com/diet/black-seed-health-benefits
  5. Hosseinzadeh H, Tavakkoli A, Mahdian V, Razavi BM. Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone. Journal of Pharmacopuncture [Internet]. 2017 Sep 30;20(3):179–93. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633670/
  6. Qenan Maxhuni, Rrahman Ferizi, Ramadan M. Black seeds (Nigella sativa) medical application and pharmaceutical perspectives. Journal of Pharmacy and Bioallied Sciences [Internet]. 2023 Jan 1;15(2):63–3. Available from: https://doi.org/10.4103%2Fjpbs.jpbs_364_22
  7. Dalli M, Bekkouch O, Azizi S, Azghar A, Gseyra N, Kim B. Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019–2021). Biomolecules. 2021 Dec 23;12(1):20.
  8. Hussain S, Aqsa Rukhsar, Iqbal M, Qurat ul Ain, Jahanzaib Fiaz, Akhtar N, et al. Phytochemical Profile, Nutritional and Medicinal Value of Nigella sativa. Biocatalysis and Agricultural Biotechnology. 2024 Jul 1;103324–4.
  9. Salehi B, Quispe C, Imran M, Ul-Haq I, Živković J, Abu-Reidah IM, et al. Nigella Plants – Traditional Uses, Bioactive Phytoconstituents, Preclinical and Clinical Studies. Frontiers in Pharmacology. 2021 Apr 26;12.
  10. Saleh FA, El-Darra N, Raafat K, Ghazzawi IE. Phytochemical Analysis of Nigella sativa L. Utilizing GC-MS Exploring its Antimicrobial Effects against Multidrug-Resistant Bacteria. Pharmacognosy Journal. 2017 Nov 26;10(1):99–105.
  11. Tiji S, Benayad O, Berrabah M, El Mounsi I, Mimouni M. Phytochemical Profile and Antioxidant Activity of Nigella sativa L Growing in Morocco. Nilashi M, editor. The Scientific World Journal. 2021 Apr 20;2021:1–12.
  12. Abbas M, Mayank Anand Gururani, Ali A, Bajwa S, Hassan R, Syeda Wajiha Batool, et al. Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. Molecules [Internet]. 2024 Oct 17;29(20):4914–4. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11510594/
  13. Jibril MM, Mohammed MB, Edeh CD, Otokpe ES, Shugaba AI, Ekwere EO. Comprehensive Analysis of Nigella sativafrom North Central Nigeria: Phytochemical, Elemental, and Potential Medicinal Properties. Computational Chemistry. 2025;13(02):33–44.
  14. National Institute of Standards and Technology. NIST Chemistry Webbook [Internet]. 2023;69. Available from: https://science.valenciacollege.edu/chemistry/appendices/appendix1-densitywatercommontemperaturespressures.pdf
  15. Thymoquinone: Uses, Interactions, Mechanism of Action | DrugBank Online [Internet]. Drugbank.com. DrugBank; 2018 [cited 2025 Aug 4]. Available from: https://go.drugbank.com/drugs/DB16447
  16. Alkharfy KM, Ahmad A, Rao, Al-Shagha WM. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. European Journal of Drug Metabolism and Pharmacokinetics. 2014 Jun 13;40(3):319–23.
  17. Asaduzzaman Khan Md, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget [Internet]. 2017 Apr 18;8(31):51907–19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584300/
  18. Zakarial Ansar FH, Latifah SY, Wan Kamal WHB, Khong KC, Ng Y, Foong JN, et al. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. International Journal of Nanomedicine. 2020 Oct;Volume 15:7703–17.
  19. Elmowafy M, Samy A, Raslan MA, Salama A, Said RA, Abdelaziz AE, et al. Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation. AAPS PharmSciTech. 2015 Aug 25;17(3):663–72.
  20. Shaukat A, Zaidi A, Anwar H, Nadeem Kizilbash. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Frontiers in Nutrition [Internet]. 2023 Sep 25;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561288/
  21. Armutcu F, Akyol S, Akyol O. The interaction of glutathione and thymoquinone and their antioxidant properties. Electronic Journal of General Medicine. 2018 Apr 15;15(4).
  22. Isaev NK, Genrikhs EE, Stelmashook EV. Antioxidant Thymoquinone and Its Potential in the Treatment of Neurological Diseases. Antioxidants [Internet]. 2023 Feb 1;12(2):433. Available from: https://www.mdpi.com/2076-3921/12/2/433
  23. Mahmoud YK, Abdelrazek HMA. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy. Biomedicine & Pharmacotherapy. 2019 Jul;115:108783.
  24. Mizuno M, Fukuhara K. Antioxidant and Prooxidant Effects of Thymoquinone and Its Hydroquinone Metabolite. Biological and Pharmaceutical Bulletin. 2022 Sep 1;45(9):1389–93.
  25. Khan A. Antioxidant and Anti-inflammatory Action of Thymoquinone. Molecular and Therapeutic actions of Thymoquinone. 2018;41–56.
  26. Liu Y, Huang L, Kim MY, Cho JY. The Role of Thymoquinone in Inflammatory Response in Chronic Diseases. International Journal of Molecular Sciences [Internet]. 2022 Jan 1;23(18):10246. Available from: https://www.mdpi.com/1422-0067/23/18/10246
  27. Kalamegam G, Alfakeeh SM, Bahmaid AO, AlHuwait EA, Gari MA, Abbas MM, et al. In vitro Evaluation of the Anti-inflammatory Effects of Thymoquinone in Osteoarthritis and in silico Analysis of Inter-Related Pathways in Age-Related Degenerative Diseases. Frontiers in Cell and Developmental Biology. 2020 Jul 23;8.
  28. Kohandel Z, Farkhondeh T, Aschner M, Samarghandian S. Anti-inflammatory effects of thymoquinone and its protective effects against several diseases. Biomedicine & Pharmacotherapy [Internet]. 2021 Jun 1;138:111492. Available from: https://www.sciencedirect.com/science/article/pii/S0753332221002778
  29. Hossen MJ, Yang WS, Kim D, Aravinthan A, Kim JH, Cho JY. Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Scientific Reports. 2017 Feb 20;7(1).
  30. Chen Y, Wang B, Zhao H. Thymoquinone reduces spinal cord injury by inhibiting inflammatory response, oxidative stress and apoptosis via PPAR‑γ and PI3K/Akt pathways. Experimental and Therapeutic Medicine. 2018 Apr 16;
  31. Tarasevičienė Ž, Laukagalis V, Paulauskienė A, Baltušnikienė A, Meškinytė E. Quality Changes of Cold-Pressed Black Cumin (Nigella sativa L.), Safflower (Carthamus tinctorius L.), and Milk Thistle (Silybum marianum L.) Seed Oils during Storage. Plants [Internet]. 2023 Jan 1;12(6):1351. Available from: https://www.mdpi.com/2223-7747/12/6/1351
  32. Jk I, Pc C. Omega-6 Fatty Acids and Inflammation [Internet]. Prostaglandins, leukotrienes, and essential fatty acids. 2018. Available from: https://pubmed.ncbi.nlm.nih.gov/29610056/
  33. Johnson M. Omega-3, Omega-6 and Omega-9 Fatty Acids: Implications for Cardiovascular and Other Diseases. Journal of Glycomics & Lipidomics. 2014;04(04).
  34. DiNicolantonio JJ, O’Keefe JH. Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation. Open Heart [Internet]. 2018 Nov;5(2):e000946. Available from: https://openheart.bmj.com/content/5/2/e000946
  35. Eid AM, Elmarzugi NA, Abu Ayyash LM, Sawafta MN, Daana HI. A Review on the Cosmeceutical and External Applications of Nigella sativa. Journal of Tropical Medicine [Internet]. 2017;2017. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735686/#sec7title
  36. Bot Verification [Internet]. Rasayanjournal.co.in. 2025. Available from: https://rasayanjournal.co.in/admin/php/upload/3354_pdf.pdf
  37. Hannan MdA, Rahman MdA, Sohag AAM, Uddin MdJ, Dash R, Sikder MH, et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients. 2021 May 24;13(6):1784.
  38. Al-Azzawi MA, AboZaid MMN, Ibrahem RAL, Sakr MA. Therapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial. Heliyon. 2020 Aug;6(8):e04711.
  39. Zahra Gholamnezhad, Shakeri F, Saadat S, Vahideh Ghorani, Boskabady MH. Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders. Avicenna Journal of Phytomedicine [Internet]. 2019 May;9(3):195. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6526035/
  40. Saadat S, Aslani MR, Ghorani V, Keyhanmanesh R, Boskabady MH. The effects of Nigella sativa on respiratory, allergic and immunologic disorders, evidence from experimental and clinical studies, a comprehensive and updated review. Phytotherapy research: PTR [Internet]. 2021 Jun 1;35(6):2968–96. Available from: https://pubmed.ncbi.nlm.nih.gov/33455047/
  41. gov. 2025 [cited 2025 Aug 4]. Available from: https://clinicaltrials.gov/study/NCT02407262
  42. Nasiri N, Mozhde Ilaghi Nezhad, Fariba Sharififar, Mahdiyeh Khazaneha, Mohammad Javad Najafzadeh, Mohamadi N. The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine [Internet]. 2022 Dec 5;2022:1–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744621/
  43. Aljabre SHM, Alakloby OM, Randhawa MA. Dermatological effects of Nigella sativa. Journal of Dermatology & Dermatologic Surgery. 2015 Jul;19(2):92–8.
  44. Derosa G, D’Angelo A, Maffioli P, Cucinella L, Rossella Elena Nappi. The Use of Nigella sativa in Cardiometabolic Diseases. Biomedicines [Internet]. 2024 Feb 9;12(2):405–5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10886913/
  45. Navid Naghsh, Amir Hossein Moridpour, Zeynab Kavyani, Vali Musazadeh, Jaber Jafarzadeh, Ehsan Safaei, et al. The effect of Nigella sativa (black seed) supplementation on body weight and body composition: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Journal of Functional Foods. 2023 Jun 1;105:105565–5.
  46. Akintunde JK, C. Abigail Irechukwu. Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats. Therapeutic advances in drug safety. 2016 Jul 22;7(4):132–46.
  47. Beheshti F, Majid Khazaei, Hosseini M. Neuropharmacological effects of Nigella sativa. Avicenna Journal of Phytomedicine [Internet]. 2016 Jan;6(1):104. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4884225/
  48. Donyavi V, Rafiee Zadeh A, Foroughi Eghbal A, Mirghazanfari S, Ghasemzadeh M, Nassireslami E. Nigella sativaextract in the treatment of depression and serum Brain-Derived Neurotrophic Factor (BDNF) levels. Journal of Research in Medical Sciences. 2022;27(1):28.
  49. Balasubramanian R, Maideen NMP, Shanmugam A. Review of the Current Clinical and Preclinical Evidence Pertaining to the Immunomodulatory Effects of Black Seeds (Nigella sativa). Acupuncture and Herbal Medicine. 2025 Feb 25;
  50. Klaudia Ciesielska-Figlon, Wojciechowicz K, Wardowska A, Lisowska KA. The Immunomodulatory Effect of Nigella sativa. Antioxidants. 2023 Jun 24;12(7):1340–0.
  51. Rahim MA, Shoukat A, Khalid W, Ejaz A, Itrat N, Majeed I, et al. A Narrative Review on Various Oil Extraction Methods, Encapsulation Processes, Fatty Acid Profiles, Oxidative Stability, and Medicinal Properties of Black Seed (Nigella sativa). Foods [Internet]. 2022 Sep 13;11(18):2826. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498113/
  52. Winatta Sakdasri, Piraya Sila-ngam, Supitcha Chummengyen, Atitaya Sukruay, Somkiat Ngamprasertsith, Wirasinee Supang, et al. Optimization of yield and thymoquinone content of screw press-extracted black cumin seed oil using response surface methodology. Industrial Crops and Products. 2023 Jan 1;191:115901–1.
  53. Khaikin E, Chrubasik-Hausmann S, Kaya S, Zimmermann BF. Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication. Nutrients [Internet]. 2022 Jan 1;14(17):3501. Available from: https://www.mdpi.com/2072-6643/14/17/3501
  54. T S . mproving the Efficiency of Extracting Nigella sativa Oil through Pretreatment: Effects on Yield and Active Constituents. International Journal of Agriculture Environment and Biotechnology. 2023 Dec 25;16(4).
  55. Mohammed NK, Abd Manap MY, Tan CP, Muhialdin BJ, Alhelli AM, Meor Hussin AS. The Effects of Different Extraction Methods on Antioxidant Properties, Chemical Composition, and Thermal Behavior of Black Seed (Nigella sativa L.) Oil. Evidence-based Complementary and Alternative Medicine : eCAM [Internet]. 2016 [cited 2020 Jun 6];2016. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015008/
  56. Alkhatib H, Mohamed F, Muhammad Eid Akkawi, Mulham Alfatama, Abd Almonem Doolaanea. Microencapsulation of black seed oil in alginate beads for stability and taste masking. Journal of Drug Delivery Science and Technology [Internet]. 2020 Aug 1;60(3):102030. Available from: https://www.researchgate.net/publication/343974111_Microencapsulation_of_black_seed_oil_in_alginate_beads_for_stability_and_taste_masking
  57. Rushmi ZT, Akter N, Mow RJ, Afroz M, Kazi M, de Matas M, et al. The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia. Saudi Pharmaceutical Journal. 2017 Mar;25(3):404–12.
  58. Priani SE, Maulidina SS, Darusman F. Development Liquid and Solid Self Microemulsifying Drug Delivery System (L-SMEDDS and S-SMEDDS) Containing Black Seed Oil (Nigella sativa L.). Journal of Pharmaceutical Research International. 2020 Dec 26;7–13.
  59. Bush B, Peña T, Bush R, Zelkha M, Lamensdorf I. Issue 1 | 1 of 5. Food Sci Nutr Res [Internet]. 3:2020. Available from: https://www.scivisionpub.com/pdfs/effects-of-standardized-black-seed-oil-cold-press-supplement-over-a-six-week-period-on-blood-pressure-and-heart-rate-in-healthy-pa-1148.pdf
  60. Sharif HR, Abbas S, Majeed H, Safdar W, Shamoon M, Khan MA, et al. Formulation, characterization and antimicrobial properties of black cumin essential oil nanoemulsions stabilized by OSA starch. Journal of Food Science and Technology. 2017 Aug 31;54(10):3358–65.
  61. Self-Assembly of Black Cumin Oil-Based Nanoemulsion on Various Surfactants: A Molecular Dynamics Study. Makara Journal of Science. 2021 Dec 30;25(4).
  62. Franklin S and. Black Seed Oil-Alginate Nanoemulsion Characteristics Utilising an Ultrasonicator at Pilot Plant Scale [Internet]. Researcherslinks.com. 2021 [cited 2025 Aug 4]. Available from: https://researcherslinks.com/current-issues/Black-Seed-Oil-Alginate-Nanoemulsion-Characteristics/14/34/10070
  63. Supriadi D, Rahmawati E, Fatmawati F. Study Effectiveness and Stability Formulation Nanoemulsion of Black Cumin Seed (Nigella sativa L.) Essential Oil: A Review. IOSR Journal Of Pharmacy And Biological Sciences (IOSR-JPBS) e [Internet]. 2022 [cited 2025 Aug 4];17:32–41. Available from: https://iosrjournals.org/iosr-jpbs/papers/Vol17-issue1/Ser-1/E1701013241.pdf
  64. Barakat ALRashdi, Massoud D, Hager Rashwan, Mahgoub S, Nermeen Abuelezz, Nasr A, et al. The Protecting Role of Black Seed Oil and Its Nano-Formulation in LPS-Induced Acute Kidney Injury in Mice: Evaluation of Oxidative Stress, Biochemical & Molecular Parameters. Journal of Inflammation Research [Internet]. 2024 Jul 1 [cited 2025 Aug 4];Volume 17:4747–63. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11268590/
  65. M R, Mt A, M A, Mhm AH, A H, D B, et al. Silver Nanoparticles from Saudi and Syrian Black Cumin Seed Extracts: Green Synthesis, ADME, Toxicity, Comparative Research, and Biological Appraisal. Journal of pharmacy & bioallied sciences [Internet]. 2023 Oct 1 [cited 2024 Jul 30];15(4). Available from: https://pubmed.ncbi.nlm.nih.gov/38235049/
  66. Shanmugam R, M. Tharani, Shahabe Saquib Abullais, Patil SR, Mohmed Isaqali Karobari. Black seed assisted synthesis, characterization, free radical scavenging, antimicrobial and anti-inflammatory activity of iron oxide nanoparticles. BMC complementary medicine and therapies. 2024 Jun 20;24(1).
  67. Al-Azzawi MA, AboZaid MMN, Ibrahem RAL, Sakr MA. Therapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial. Heliyon. 2020 Aug;6(8):e04711.
  68. Alabdullah M, Kara Beit ZZ, Shehada A. Comparative Clinical Study of the Effect of Nigella Sativa Oil on Soft Tissue Healing and Inflammation Reduction Compared to Eugenol in the Context of Dry Socket. Cureus. 2023 Feb 23;
  69. Khan ZA, Prabhu N, Ahmed N, Lal A, Issrani R, Maqsood A, et al. A Comparative Study on Alvogyl and a Mixture of Black Seed Oil and Powder for Alveolar Osteitis: A Randomized Double-Blind Controlled Clinical Trial. International Journal of Clinical Practice [Internet]. 2022 [cited 2024 Apr 20];2022:7756226. Available from: https://pubmed.ncbi.nlm.nih.gov/35685605/
  70. Azizi F, Ghorat F, Hassan Rakhshani M, Rad M. Comparison of the effect of topical use of Nigella Sativa oil and diclofenac gel on osteoarthritis pain in older people: A randomized, double-blind, clinical trial. Journal of Herbal Medicine. 2019 Jun;16:100259.
  71. Adedokun MA, Enye LA, Akinluyi ET, Ajibola TA, Edem EE. Black seed oil reverses chronic antibiotic-mediated depression and social behaviour deficits via modulation of hypothalamic mitochondrial-dependent markers and insulin expression. IBRO neuroscience reports [Internet]. 2024 Jun 1;16:267–79. Available from: https://pubmed.ncbi.nlm.nih.gov/38379607/
  72. Elham Razmpoosh, Safi S, Mazaheri M, Saman Khalesi, Nazari M, Parvin Mirmiran, et al. A crossover randomized controlled trial examining the effects of black seed (Nigella sativa) supplementation on IL-1β, IL-6 and leptin, and insulin parameters in overweight and obese women. BMC Complementary Medicine and Therapies. 2024 Jan 5;24(1).
  73. Karaarslan O, Ersoy S, Pala E, Engin VS. The efficacy of Nigella sativa oil in the prophylaxis and treatment of upper respiratory tract infections in children. Journal of Functional Foods [Internet]. 2024 Apr 27;116:106193. Available from: https://www.sciencedirect.com/science/article/pii/S175646462400195
  74. Mashayekhi-Sardoo H, Rezaee R, Karimi G. Nigella sativa (black seed) safety: an overview. Asian Biomedicine. 2020 Aug 1;14(4):127–37.
  75. Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine. 2002 Jan;9(1):69–74.
  76. Akrom Akrom, Endang Darmawan. Tolerability and safety of black cumin seed oil (Bcso) administration for 20 days in healthy subjects. Biomedical Research-tokyo. 2017 Feb 28;28(9):4196–201.
  77. Shakeri F, Zahra Gholamnezhad, Mégarbane B, Ramin Rezaee, Boskabady MH. Gastrointestinal effects of Nigella sativa and its main constituent, thymoquinone: a review. Avicenna Journal of Phytomedicine [Internet]. 2016 Jan;6(1):9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4884214/
  78. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Research [Internet]. 2003 Apr;17(4):299–305. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.1309
  79. Polat EC, Salih Zorbuna, Alparslan Koç. Black seed oil induced acute liver failure: a case report and literature review. Journal of Comprehensive Surgery. 2025 May 8;3(2):37–9.
  80. Sener K, Cakir A, Yesiloglu O, Altug E, Guven R, Korkut S. Rhabdomyolysis and acute kidney injury after consumption of black seed oil. Toxicon [Internet]. 2024 Jun 4;245:107787. Available from: https://www.sciencedirect.com/science/article/pii/S0041010124003593?via=ihub
  81. Ramalingam K, Ramadasan Kuttan, Syam Das Sivadasan, Sibi Ittiyavirah, Krishnakumar Illathu Madhavamenon. Safety Assessment of Thymoquinone-rich Black Cumin (Nigella sativa) Oil (BlaQmax®): Acute and Sub-chronic Toxicity Studies. Journal of Nutrition & Food Sciences. 2021 Jan 1;1–4.
  82. Black Seed: Uses, Side Effects, Interactions, Dosage, and Warning [Internet]. Webmd.com. 2019. Available from: https://www.webmd.com/vitamins/ai/ingredientmono-901/black-seed
  83. Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, et al. Nigella sativa and health outcomes: An overview of systematic reviews and meta-analyses. Frontiers in Nutrition. 2023 Mar 28;10.
  84. Annisa Evanti, Wargasetia T, Gunadi J. Role of Nigella sativa seed (black cumin) in preventing photoaging (Review). Biomedical Reports. 2025 Jun 4;23(2):1–13.
  85. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytotherapy Research. 2004 Mar;18(3):195–9.
  86. Usmani A, Almoselhy, Rania I.M. Current Trends in Nigella Sativa L. (Black Seed) From Traditional to Modern Medicine With Advances in Extraction, Formulation, Quality Control, Regulatory Status, and Pharmacology. SSRN Electronic Journal. 2024 Jan 1;